Announcements

Aims & Scope


Cellular Reprogramming is the premier journal dedicated to providing new insights on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms. The Journal delivers information on cutting-edge techniques and the latest high-quality research and discoveries that are transforming biomedical research.

Cellular Reprogramming coverage includes:

  • Somatic cell nuclear transfer and reprogramming in early embryos
  • Embryonic stem cells
  • Nuclear transfer stem cells (stem cells derived from nuclear transfer embryos)
  • Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based therapies
  • Epigenetics
  • Adult stem cells and pluripotency

Cellular Reprogramming is under the editorial leadership of Editor-in-Chief Professor Sir Ian Wilmut, OBE FRS FRSE, MRC Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine, University of Edinburgh; Deputy Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine, University of Edinburgh; and other leading investigators. View the entire editorial board.

Audience: Cell biologists, embryologists, developmental biologists, genetic engineers, cloning scientists, stem cell researchers, and tissue engineers, among others.

Indexed/Abstracted in:

MEDLINE;

PubMed;

PubMed Central;

Science Citation Index Expanded;

BIOSIS Previews;

Biotechnology Citation Index®;

Biological Abstracts;

EMBASE/Excerpta Medica;

EMBiology;

Scopus;

AGRICOLA;

Chemical Abstracts;

ProQuest databases;

CAB Abstracts;

Global Health;

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Upcoming Events

Dec 08 - Dec 12, 2018